Burch, L; Lampe, FC; Smith, C; Anderson, J; Sherr, L; Rodger, A; O'Connell, R; ... Johnson, M; + view all Burch, L; Lampe, FC; Smith, C; Anderson, J; Sherr, L; Rodger, A; O'Connell, R; Geretti, A; Gilson, R; Fisher, M; Elford, J; Jones, M; Collins, S; Azad, Y; Phillips, A; Speakman, A; Johnson, M; - view fewer (2016) Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses. The Lancet Public Health , 1 (1) e26-e36. 10.1016/S2468-2667(16)30002-0.

Preview

Text Socioeconomic status and treatment outcomes for indiciduals with HIV.pdf - Published Version Download (576kB) | Preview

Abstract

BACKGROUND: Few studies have assessed the eff ect of socioeconomic status on HIV treatment outcomes in settings with universal access to health care. Here we aimed to investigate the association of socioeconomic factors with antiretroviral therapy (ART) non-adherence, virological non-suppression, and virological rebound, in HIV-positive people on ART in the UK. METHODS: We used data from the Antiretrovirals, Sexual Transmission Risk and Attitudes (ASTRA) questionnaire study, which recruited participants aged 18 years or older with HIV from eight HIV outpatient clinics in the UK between Feb 1, 2011, and Dec 31, 2012. Participants self -completed a confi dential questionnaire on sociodemographic, health, and lifestyle issues. In participants on ART, we assessed associations of fi nancial hardship, employment, housing, and education with: self-reported ART non-adherence at the time of the questionnaire; virological non-suppression (viral load >50 copies per mL) at the time of questionnaire in those who started ART at least 6 months ago (cross-sectional analysis); and subsequent virological rebound (viral load >200 copies per mL) in those with initial viral load of 50 copies per mL or lower (longitudinal analysis). Findings Of the 3258 people who completed the questionnaire, 2771 (85%) reported being on ART at the time of the questionnaire, and 2704 with complete data were included. 873 (32%) of 2704 participants reported non-adherence to ART and 219 (9%) of 2405 had virological non-suppression in cross-sectional analysis. Each of the four measures of lower socioeconomic status was strongly associated with non-adherence to ART, and with virological non-suppression (prevalence ratios [PR] adjusted for gender/sexual orientation, age, and ethnic origin: greatest financial hardship vs none 2·4, 95% CI 1·6–3·4; non-employment 2·0, 1·5–2·6; unstable housing vs homeowner 3·0, 1·9–4·6; non-university education 1·6, 1·2–2·2). 139 (8%) of 1740 individuals had subsequent virological rebound (rate=3·6/100 person-years). Low socioeconomic status was predictive of longitudinal rebound risk (adjusted hazard ratio [HR] for greatest fi nancial hardship vs none 2·3, 95% CI 1·4–3·9; non-employment 3·0, 2·1–4·2; unstable housing vs homeowner 3·3, 1·8–6·1; non-university education 1·6, 1·1–2·3). INTERPRETATION: Socioeconomic disadvantage was strongly associated with poorer HIV treatment outcomes in this setting with universal health care. A dherence interventions and increased social support for those most at risk should be considered.

Download activity - last month

Export as CSVXMLJSON

Download activity - last 12 months

Export as XMLCSVJSON

Downloads by country - last 12 months

Export as JSONXMLCSV

Archive Staff Only

View Item